Acer Therapeutics Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Acer Therapeutics Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2023.
  • Acer Therapeutics Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2023 was 24.5M shares, a 49.4% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 24.5M +8.09M +49.4% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 24.5M +8.79M +56.1% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 23.4M +9.11M +63.7% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 19.6M +5.31M +37.1% Dec 31, 2022 10-Q 2023-11-20
Q3 2022 16.4M +2.06M +14.4% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 15.7M +1.36M +9.52% Jun 30, 2022 10-Q/A 2022-11-14
Q1 2022 14.3M 0 0% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 14.3M +1.08M +8.14% Dec 31, 2021 10-K 2023-03-27
Q3 2021 14.3M +2.4M +20.1% Sep 30, 2021 10-Q 2021-11-19
Q2 2021 14.3M +3.7M +34.8% Jun 30, 2021 10-Q/A 2021-11-19
Q1 2021 14.3M +4.21M +41.7% Mar 31, 2021 10-Q/A 2021-11-19
Q4 2020 13.2M +3.14M +31.1% Dec 31, 2020 10-K 2022-03-02
Q3 2020 11.9M +1.82M +18% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 10.6M +518K +5.13% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 10.1M +13.7K +0.14% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 10.1M +7.81K +0.08% Dec 31, 2019 10-K 2021-03-01
Q3 2019 10.1M +42.2K +0.42% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 10.1M +2.6M +34.6% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 10.1M +2.59M +34.5% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 10.1M +2.59M +34.5% Dec 31, 2018 10-K 2020-03-18
Q3 2018 10.1M +3.6M +55.8% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 7.5M -160K -2.09% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 7.5M -160K -2.09% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 7.5M +5.05M +206% Dec 31, 2017 10-K 2019-03-07
Q3 2017 6.45M -690K -9.67% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 7.66M +608K +8.63% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 7.66M +674K +9.66% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 2.45M -4.53M -64.9% Dec 31, 2016 10-K 2018-03-07
Q3 2016 7.14M +277K +4.03% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 7.05M -46.3M -86.8% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 6.98M -21.3M -75.3% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 6.98M +3.45M +97.9% Dec 31, 2015 10-K 2017-03-28
Q3 2015 6.86M -21.3M -75.6% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 53.4M +25.7M +93% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 28.3M +594K +2.15% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 3.53M -24M -87.2% Dec 31, 2014 10-K 2016-03-15
Q3 2014 28.2M +5.45M +24% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 27.7M +19.7M +246% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 27.7M +19.7M +246% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 27.5M +21.3M +341% Dec 31, 2013 10-K 2015-02-23
Q3 2013 22.7M -319K -1.38% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 7.99M -15.1M -65.3% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 7.99M -15.1M -65.3% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 6.25M +487K +8.46% Dec 31, 2012 10-K 2014-02-27
Q3 2012 23M 0 0% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 23M 0 0% Jun 30, 2012 10-Q 2012-08-13
Q1 2012 23M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 5.76M -12.7M -68.8% Dec 31, 2011 10-K 2013-03-29
Q3 2011 23M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 23M Jun 30, 2011 10-Q 2011-08-11
Q4 2010 18.5M Dec 31, 2010 10-K 2012-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.